Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First hospitalised COVID-19 patient dosed in FSD201 treatment trial

europeanpharmaceuticalreviewDecember 18, 2020

Tag: FSD201 , COVID-19 , FSD Pharma , SOC

PharmaSources Customer Service